These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 31489746)
1. Oral prescription opioid-seeking behavior in male and female mice. Phillips AG; McGovern DJ; Lee S; Ro K; Huynh DT; Elvig SK; Fegan KN; Root DH Addict Biol; 2020 Nov; 25(6):e12828. PubMed ID: 31489746 [TBL] [Abstract][Full Text] [Related]
2. Pivotal role of orexin signaling in the posterior paraventricular nucleus of the thalamus during the stress-induced reinstatement of oxycodone-seeking behavior. Illenberger JM; Flores-Ramirez FJ; Pascasio G; Franco M; Mendonsa B; Martin-Fardon R J Psychopharmacol; 2024 Jul; 38(7):647-660. PubMed ID: 38888086 [TBL] [Abstract][Full Text] [Related]
3. Sex differences in oral oxycodone self-administration and stress-primed reinstatement in rats. Fulenwider HD; Nennig SE; Hafeez H; Price ME; Baruffaldi F; Pravetoni M; Cheng K; Rice KC; Manvich DF; Schank JR Addict Biol; 2020 Nov; 25(6):e12822. PubMed ID: 31830773 [TBL] [Abstract][Full Text] [Related]
4. The novel dopamine D3 receptor antagonists/partial agonists CAB2-015 and BAK4-54 inhibit oxycodone-taking and oxycodone-seeking behavior in rats. You ZB; Gao JT; Bi GH; He Y; Boateng C; Cao J; Gardner EL; Newman AH; Xi ZX Neuropharmacology; 2017 Nov; 126():190-199. PubMed ID: 28888944 [TBL] [Abstract][Full Text] [Related]
5. Role of mu, but not delta or kappa, opioid receptors in context-induced reinstatement of oxycodone seeking. Bossert JM; Hoots JK; Fredriksson I; Adhikary S; Zhang M; Venniro M; Shaham Y Eur J Neurosci; 2019 Aug; 50(3):2075-2085. PubMed ID: 29779230 [TBL] [Abstract][Full Text] [Related]
6. In a Rat Model of Opioid Maintenance, the G Protein-Biased Mu Opioid Receptor Agonist TRV130 Decreases Relapse to Oxycodone Seeking and Taking and Prevents Oxycodone-Induced Brain Hypoxia. Bossert JM; Kiyatkin EA; Korah H; Hoots JK; Afzal A; Perekopskiy D; Thomas S; Fredriksson I; Blough BE; Negus SS; Epstein DH; Shaham Y Biol Psychiatry; 2020 Dec; 88(12):935-944. PubMed ID: 32305216 [TBL] [Abstract][Full Text] [Related]
7. Comparing withdrawal- and anxiety-like behaviors following oral and subcutaneous oxycodone administration in C57BL/6 mice. De Almeida SS; Drinkuth CR; Sartor GC Behav Pharmacol; 2024 Aug; 35(5):269-279. PubMed ID: 38847447 [TBL] [Abstract][Full Text] [Related]
8. Oxycodone physical dependence and its oral self-administration in C57BL/6J mice. Enga RM; Jackson A; Damaj MI; Beardsley PM Eur J Pharmacol; 2016 Oct; 789():75-80. PubMed ID: 27393461 [TBL] [Abstract][Full Text] [Related]
9. Effect of the dopamine stabilizer (-)-OSU6162 on potentiated incubation of opioid craving after electric barrier-induced voluntary abstinence. Fredriksson I; Applebey SV; Minier-Toribio A; Shekara A; Bossert JM; Shaham Y Neuropsychopharmacology; 2020 Apr; 45(5):770-779. PubMed ID: 31905372 [TBL] [Abstract][Full Text] [Related]
10. Ranking the contribution of behavioral measures comprising oxycodone self-administration to reinstatement of drug-seeking in male and female rats. Guha SK; Alonso-Caraballo Y; Driscoll GS; Babb JA; Neal M; Constantino NJ; Lintz T; Kinard E; Chartoff EH Front Behav Neurosci; 2022; 16():1035350. PubMed ID: 36505730 [TBL] [Abstract][Full Text] [Related]
11. Dietary Supplementation with Omega-3 Polyunsaturated Fatty Acids Reduces Opioid-Seeking Behaviors and Alters the Gut Microbiome. Hakimian JK; Dong TS; Barahona JA; Lagishetty V; Tiwari S; Azani D; Barrera M; Lee S; Severino AL; Mittal N; Cahill CM; Jacobs JP; Walwyn WM Nutrients; 2019 Aug; 11(8):. PubMed ID: 31416242 [TBL] [Abstract][Full Text] [Related]
12. Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats. Matzeu A; Martin-Fardon R Neuropharmacology; 2020 Mar; 164():107906. PubMed ID: 31841797 [TBL] [Abstract][Full Text] [Related]
13. Female and male rats readily consume and prefer oxycodone to water in a chronic, continuous access, two-bottle oral voluntary paradigm. Zanni G; DeSalle MJ; Deutsch HM; Barr GA; Eisch AJ Neuropharmacology; 2020 May; 167():107978. PubMed ID: 32001238 [TBL] [Abstract][Full Text] [Related]